IWP Capital, a co-filer of FedEx Proposal 6, plans to vote for the measure at the company's 2026 annual meeting. The proposal concerns legal, regulatory, and reputational risks associated with FedEx's distribution of abortion drugs and asks the board to report on how those risks are managed within one year. The development is an FDX stock news item.